Add prophylaxis for patients receiving systemic therapy
Enroll patients now in KEYNOTE-630 trial
Study findings presented at ASCO 2019
Another option for immunotherapy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Reducing uncollectible revenue, financial burden
Drug stimulates an immune response to survivin
Advertisement
Advertisement